Advertisement · 728 × 90
#
Hashtag
#experimentAversion
Advertisement · 728 × 90
Rosenbaum, Gail, Amir Goren, Maheen Shermohammed, Donna M. Wolk, Ann Marie Tice, Joseph Doyle, Michelle Meyer, and Christopher F. Chabris. “Algorithm Aversion or Appreciation? Three Randomized Field Trials of Personalized Risk-Communication Nudges to Encourage Flu Vaccination,” June 22, 2023. https://doi.org/10.31234/osf.io/vtxza.

Rosenbaum, Gail, Amir Goren, Maheen Shermohammed, Donna M. Wolk, Ann Marie Tice, Joseph Doyle, Michelle Meyer, and Christopher F. Chabris. “Algorithm Aversion or Appreciation? Three Randomized Field Trials of Personalized Risk-Communication Nudges to Encourage Flu Vaccination,” June 22, 2023. https://doi.org/10.31234/osf.io/vtxza.

Vogt, R. L., Heck, P. R., Mestechkin, R. M., Heydari, P., Chabris, C. F., & Meyer, M. N. (2024). Aversion to pragmatic randomised controlled trials: Three survey experiments with clinicians and laypeople in the USA. BMJ Open, 14(9), e084699. https://doi.org/10.1136/bmjopen-2024-084699

Vogt, R. L., Heck, P. R., Mestechkin, R. M., Heydari, P., Chabris, C. F., & Meyer, M. N. (2024). Aversion to pragmatic randomised controlled trials: Three survey experiments with clinicians and laypeople in the USA. BMJ Open, 14(9), e084699. https://doi.org/10.1136/bmjopen-2024-084699

Title: Algorithm aversion or appreciation? Four randomized field trials of personalized riskcommunication nudges to encourage flu vaccination Authors: Christopher F. Chabris, Gail M. Rosenbaum, Amir Goren, Maheen Shermohammed, Donna M. Wolk, Ann Marie Tice, Joseph Doyle, Michelle N. Meyer

Title: Algorithm aversion or appreciation? Four randomized field trials of personalized riskcommunication nudges to encourage flu vaccination Authors: Christopher F. Chabris, Gail M. Rosenbaum, Amir Goren, Maheen Shermohammed, Donna M. Wolk, Ann Marie Tice, Joseph Doyle, Michelle N. Meyer

Title: Timely nudges promote patient portal enrollment and sustained engagement: Evidence from a prospective randomized trial Authors: Amir Goren, Sasha C. Brietzke, Maheen Shermohammed, Gail M. Rosenbaum, Michelle N. Meyer, Christopher F. Chabris

Title: Timely nudges promote patient portal enrollment and sustained engagement: Evidence from a prospective randomized trial Authors: Amir Goren, Sasha C. Brietzke, Maheen Shermohammed, Gail M. Rosenbaum, Michelle N. Meyer, Christopher F. Chabris

#HealthScience is alive and well at #Geisinger!

Some #Research Symposium highlights
- #GLP1 protocol testing
- #AI-assisted #risk assessment
- #experimentAversion
- #health #nudges
- Dr. Todd Rice on #Vanderbilt's pragmatic trials

Abstracts + #dataViz: ugc.production.linkt...

0 0 0 0
Figure 3. Clinician sentiments about COVID-19 pragmatic randomised controlled trials (pRCTs). (A) Mean appropriateness ratings, on a 1–5 scale, with standard errors, for intervention A, intervention B, the highest-rated intervention, the average intervention, the lowest-rated intervention and the A/B test. Circles represent measures directly collected from participants. Triangles represent averages derived from the direct measures. The distance of the mean appropriateness of the lowest-rated intervention (brown triangle) minus the mean appropriateness of the A/B test (orange circle) represents experiment aversion. The distance of the mean appropriateness of the average intervention (gray triangle) minus the mean appropriateness of the A/B test (orange circle) represents the A/B effect. The distance of the mean appropriateness of the A/B test (orange circle) minus the mean appropriateness of the highest-rated intervention (purple triangle) represents experiment appreciation.

(B) Appropriateness ratings transformed into percentages and standard errors of participants objecting (defined as assigning a rating of 1 or 2—‘very inappropriate’ or ‘somewhat inappropriate’— on a 1–5 scale) to implementing intervention A, intervention B and the A/B test.

Vogt, R. L., Heck, P. R., Mestechkin, R. M., Heydari, P., Chabris, C. F., & Meyer, M. N. (2024). Aversion to pragmatic randomised controlled trials: Three survey experiments with clinicians and laypeople in the USA. BMJ Open, 14(9), e084699. https://doi.org/10.1136/bmjopen-2024-084699

Figure 3. Clinician sentiments about COVID-19 pragmatic randomised controlled trials (pRCTs). (A) Mean appropriateness ratings, on a 1–5 scale, with standard errors, for intervention A, intervention B, the highest-rated intervention, the average intervention, the lowest-rated intervention and the A/B test. Circles represent measures directly collected from participants. Triangles represent averages derived from the direct measures. The distance of the mean appropriateness of the lowest-rated intervention (brown triangle) minus the mean appropriateness of the A/B test (orange circle) represents experiment aversion. The distance of the mean appropriateness of the average intervention (gray triangle) minus the mean appropriateness of the A/B test (orange circle) represents the A/B effect. The distance of the mean appropriateness of the A/B test (orange circle) minus the mean appropriateness of the highest-rated intervention (purple triangle) represents experiment appreciation. (B) Appropriateness ratings transformed into percentages and standard errors of participants objecting (defined as assigning a rating of 1 or 2—‘very inappropriate’ or ‘somewhat inappropriate’— on a 1–5 scale) to implementing intervention A, intervention B and the A/B test. Vogt, R. L., Heck, P. R., Mestechkin, R. M., Heydari, P., Chabris, C. F., & Meyer, M. N. (2024). Aversion to pragmatic randomised controlled trials: Three survey experiments with clinicians and laypeople in the USA. BMJ Open, 14(9), e084699. https://doi.org/10.1136/bmjopen-2024-084699

One premise in the argument 👆 seemed risky: randomly selecting between two seemingly equally acceptable treatments is NOT a sufficient justification to select one or the other treatment.

When asked, the reason for this #experimentAversion bias (doi.org/10.1136/bmjo...) was intuition and status quo.

1 0 1 0